Sort
8,912 grants matching “sars cov 2”
Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses
$216,250Thomas M. Aune · Vanderbilt University Medical Center · R21 · FY2023 · AI
Molecular Biology of Viral Diseases
$216,208Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · T32 · FY2008 · AI
CRISPR-Cas9 Screen for SARS-CoV-2 Host Dependency Factors
$216,185Alex Compton · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Defining the optimal type and timing of COVID-19 vaccine in pregnancy
$216,125Ai-Ris Yonekura Collier · Beth Israel Deaconess Medical Center · R21 · FY2022 · AI
Development and Characterization of Phage QBeta-Based SARS-CoV-2 RT-qPCR Assay Calibration Standards
$216,125James E Kirby · Beth Israel Deaconess Medical Center · R21 · FY2024 · AI
COVID-19 Infection and Diabetes Incidence in Native Americans
$216,057Mary E. Lacy · University Of Kentucky · R34 · FY2022 · DK
Microbiota-Mediated Bidirectional Interactions Between Alcohol Misuse and Post-COVID-19 Syndrome
$215,870Ali Keshavarzian · Rush University Medical Center · R01 · FY2021 · AA
Modeling and data analysis of complex diseases
$215,771Carson Chow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Project-002
$215,682Leonidas A Stamatatos · Fred Hutchinson Cancer Center · U19 · FY2025 · AI
Probiotics that moderate pH and antagonize pathogens to promote oral health
$215,292Robert A Burne · University Of Florida · R01 · FY2020 · DE
Dissecting mechanisms of antibody-Fc interactions that shape innate immune antiviral responses.
$215,261Bronwyn Mei Gunn · Washington State University · R21 · FY2025 · AI
Signaling Core
$215,216Garry P Nolan · Scripps Research Institute, The · U19 · FY2020 · AI
Host genetic resistance to COVID-19
$215,105Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses
$215,100Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
RAPID: Predicting Coronavirus Disease (COVID-19) Impact with Multiscale Contact and Transmission Mitigation
$215,000Arshad A Kudrolli · Clark University · · FY2020 · MPS
Investigation of sarbecovirus exposure patterns and development of pan-SARS-CoV-2 neutralizing antibody responses in high-risk cohorts in Myanmar
$214,874Tierra Smiley Evans · University Of California At Davis · R21 · FY2024 · AI
Embedded Printing of Human Respiratory Model with Air-Liquid Interface for COVID-19 Research
$214,733Yong Huang · University Of Florida · R21 · FY2023 · HL
Prevalence of Coronaviruses in Wild Rodents
$214,725William A Schountz · Colorado State University · R21 · FY2024 · AI
Mechanisms of antiviral immunity and tolerance in the intestinal epithelium of Jamaican Fruit Bats
$214,575Diane Bimczok · Montana State University - Bozeman · R21 · FY2023 · AI
A Longitudinal Study of COVID-19 Sequelae and Immunity
$214,526Michael C Sneller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Evaluation of iDMV-1.0: A Single Dose Self-Amplifying Vaccine for SARS-CoV-2
$214,525Devdoot Majumdar · University Of Vermont & St Agric College · P20 · FY2025 · GM
RNA viruses of pandemic potential - viral infectivity
$214,525Emily A. Bruce · University Of Vermont & St Agric College · P20 · FY2025 · GM
Investigating the roles of Topoisomerase 3b-TDRD3 complex in neurodegeneration and Alzheimer's disease
$213,612Weidong Wang · National Institute On Aging · ZIA · FY2021 · AG
RNA viruses of pandemic potential - viral infectivity
$213,501Emily A. Bruce · University Of Vermont & St Agric College · P20 · FY2024 · GM
Serologic studies of persons with COVID-19 infection
$213,441Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI